Pharmaqo IGF-1 LR3
The insulin-like Growth Factor is one of the endocrine hormones produced by the liver (IGF-1). The release of this hormone increases in the presence of a Human Growth Hormone. Insulin-like Growth Factor receptors with a high affinity may be discovered in numerous cells throughout the human body’s muscles. This makes it one of the best growth hormones and a promoter of general cell development, which it accomplishes by targeting specific tissues and encouraging cell division through more autocrine cell communication methods. Bone production requires appropriate amounts of IGF-1 and growth hormone during childhood and maturity.
IGF-1 has a number of advantages.
- Protein synthesis in the body
- The body’s fat store is shifted to energy production, resulting in considerable fat loss.
- Positive effects on metabolism, fat reduction, and lean body mass
- The ability of the body’s nerve tissues to regenerate is improved.
- Increases antioxidant protection and ligament strength.
- Muscle cell hyperplasia is enhanced, resulting in fuller muscular tissues.
- Improved cognitive abilities
About IGF-1 LR3
The half-life of IGF-1 LR3 is around 20–30 hours. It’s more powerful than regular IGF-1. It connects to cell receptors in muscle cells and begins cell communication, allowing muscles to develop at a higher rate throughout the day since it may stay in the body for more than a day. IGF-1 LR3 blocks glucose from entering body cells, allowing fat to be burned and fat to be used for energy production. Because site injections are never required, the majority of patients and physicians prefer them because they have a nearly one-day lifespan. IGF-1 LR3 travels throughout the body, connects to muscle cell receptors, and then acts for about a day, thus this dosage should be taken on a daily basis.
Dosage
This IGF-1 variant should be taken seven days a week, every day. Because desensitization occurs, the process should not go more than 90 days. You should take a rest before commencing therapy again. Various therapy options are available during the interim.
Pharmaqo IGF-1 LR3 Side Effects
IGF-1 can cause hypoglycemia in big doses, although it’s not as serious as insulin-induced hypoglycemia. This is the most common negative impact. The potential that IGF-1 may promote tumor development in cancer patients is a heated topic of debate. IGF-1 does not cause cancer, despite the fact that it may be true in those who already have cancer. In actuality, the human body needs IGF-1 to regulate heart activity, activate brain cells, and increase nervous system performance.
